Benitec Biopharma Valuation
| BNTC Stock | USD 11.49 0.58 5.32% |
At this time, the firm appears to be overvalued. Benitec Biopharma shows a prevailing Real Value of $9.34 per share. The current price of the firm is $11.49. Our model approximates the value of Benitec Biopharma from analyzing the firm fundamentals such as Shares Owned By Insiders of 4.38 %, return on equity of -0.92, and Current Valuation of 185.66 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Benitec Biopharma's valuation include:
Price Book 3.9466 | Enterprise Value | Enterprise Value Ebitda 0.2655 | Price Sales 2.8 K | Enterprise Value Revenue 10.5 K |
Overvalued
Today
Please note that Benitec Biopharma's price fluctuation is slightly risky at this time. Calculation of the real value of Benitec Biopharma is based on 3 months time horizon. Increasing Benitec Biopharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Benitec Biopharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Benitec Stock. However, Benitec Biopharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 11.49 | Real 9.34 | Target 24.0 | Hype 10.91 | Naive 12.05 |
The real value of Benitec Stock, also known as its intrinsic value, is the underlying worth of Benitec Biopharma Company, which is reflected in its stock price. It is based on Benitec Biopharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Benitec Biopharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Benitec Biopharma Ltd helps investors to forecast how Benitec stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Benitec Biopharma more accurately as focusing exclusively on Benitec Biopharma's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Benitec Biopharma's intrinsic value based on its ongoing forecasts of Benitec Biopharma's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Benitec Biopharma's closest peers. If more than one evaluation category is relevant for Benitec Biopharma we suggest using both methods to arrive at a better estimate.
Benitec Biopharma Cash |
|
Benitec Valuation Trend
Comparing Benitec Biopharma's enterprise value against its market capitalization is a good way to estimate the value of Benitec Biopharma Ltd uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Benitec Revenue by Product
Benitec Biopharma Total Value Analysis
Benitec Biopharma Ltd is currently anticipated to have valuation of 185.66 M with market capitalization of 215.39 M, debt of 284 K, and cash on hands of 4.06 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Benitec Biopharma fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
185.66 M | 215.39 M | 284 K | 4.06 M |
Benitec Biopharma Investor Information
About 46.0% of the company shares are held by institutions such as insurance companies. The book value of Benitec Biopharma was currently reported as 4.68. The company recorded a loss per share of 5.51. Benitec Biopharma last dividend was issued on the 18th of November 2019. The entity had 1:17 split on the 26th of July 2023. Based on the key measurements obtained from Benitec Biopharma's financial statements, Benitec Biopharma Ltd may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.Benitec Biopharma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Benitec Biopharma has an asset utilization ratio of 0.41 percent. This indicates that the Company is making $0.004137 for each dollar of assets. An increasing asset utilization means that Benitec Biopharma Ltd is more efficient with each dollar of assets it utilizes for everyday operations.Benitec Biopharma Ownership Allocation
Benitec Biopharma holds a total of 19.82 Million outstanding shares. 30% of Benitec Biopharma Ltd outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Benitec Biopharma Profitability Analysis
The company reported the previous year's revenue of 216 K. Net Loss for the year was (21.75 M) with profit before overhead, payroll, taxes, and interest of 75 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Benitec Biopharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Benitec Biopharma and how it compares across the competition.
About Benitec Biopharma Valuation
The stock valuation mechanism determines Benitec Biopharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of Benitec Biopharma. We calculate exposure to Benitec Biopharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Benitec Biopharma's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 97.2 K | 92.3 K | |
| Pretax Profit Margin | (119.10) | (125.05) | |
| Operating Profit Margin | (119.74) | (125.73) | |
| Net Loss | (115.80) | (121.59) | |
| Gross Profit Margin | 0.57 | 0.60 |
Benitec Biopharma Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 4.1 M |
Benitec Biopharma Current Valuation Indicators
Valuation refers to the process of determining the present value of Benitec Biopharma Ltd and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Benitec we look at many different elements of the entity such as Benitec's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Benitec Biopharma, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Benitec Biopharma's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Benitec Biopharma's worth.Complementary Tools for Benitec Stock analysis
When running Benitec Biopharma's price analysis, check to measure Benitec Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Benitec Biopharma is operating at the current time. Most of Benitec Biopharma's value examination focuses on studying past and present price action to predict the probability of Benitec Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Benitec Biopharma's price. Additionally, you may evaluate how the addition of Benitec Biopharma to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |